Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

Fig. 1

a The platelet counts after lusutrombopag treatment in all patients (left panel, n = 31), group A (middle panel, n = 23), and group B (right panel, n = 8). b The platelet count in patients who received platelet transfusion after lusutrombopag treatment (n = 7). **p < 0.01, n.s not significant, LUS lusutrombopag, PTF platelet transfusion

Back to article page